Objective In this study, health-related quality of life (HRQoL) and its determinants were assessed in breast cancer patients undergoing postoperative adjuvant radiotherapy. The aim was to improve our understanding of patient's situation at the end of adjuvant treatment, as the return to every day life approaches after breast cancer surgery and adjuvant chemo-and radiotherapy. Methods Health-related quality of life was measured by the 15D instrument. Self-administered questionnaires were distributed to patients undergoing postoperative radiotherapy. Out of 389 consecutive breast cancer patients, 273 comprised the final study group. The results were compared to 15D results for an age-standardized sample of the female general population in Finland (n = 3,335). Determinants of HRQoL were assessed by a multivariate model. Results In patients\53 years, but not in older patients, the total 15D score was lower than in age-standardized controls. Both younger and older patients differed significantly from the controls on specific 15D dimensions of sleeping, depression, distress, vitality, and sexual activity. When clinical and treatment variables were assessed by a multivariate model, depressive symptoms had a negative effect on HRQoL. Further, having undergone breast conserving surgery instead of mastectomy was associated with poorer HRQoL. Conclusions Impairment of HRQoL was observed during adjuvant radiotherapy in breast cancer. This finding calls for action to develop supportive and preventive means to smoothen the return to normal activities after completion of adjuvant treatment for breast cancer.
Quality of life is most affected by chemotherapy, while during radiotherapy the physical problems associated with neutropenia, loss of hair, peripheral neuropathy, nausea and vomiting, and even cognitive impairment and vulnerability to system toxicity no longer persist or increase as they do during repeated chemotherapy cycles. It has been suggested, however, that tiredness may increase during radiotherapy [2] . It has also been shown that nearly a third of patients during adjuvant radiotherapy suffer from depressive symptoms and more than a quarter have distress [3] . Breast cancer patients are often at the age, where menopausal changes produce vulnerability similar to the effects of chemotherapy on hormonal and mental characteristics. We therefore sought to establish whether the health-related quality of life (HRQoL) of breast cancer patients differs significantly from that of the general Finnish female population of the same age. There are previous studies on HRQoL comparing breast cancer patients with the general female population [4] [5] [6] [7] [8] [9] , but to our knowledge no such comparison has been made with breast cancer patients during adjuvant radiotherapy.
The aims of the current study were as follows:
1. To describe and to compare the HRQoL of breast cancer patients in adjuvant radiotherapy with agestandardized female general population. 2. To assess the effect of clinical and treatment factors on the HRQoL of breast cancer patients in adjuvant radiotherapy.
Materials and methods

General design
At the Department of Oncology and Radiotherapy, in Turku University Hospital, consecutive breast cancer patients receiving postoperative radiotherapy were asked to participate in this survey study. Collection of data took place in June 2006-December 2007. Questionnaires assessing HRQoL and depressive symptoms were distributed to the patients by the staff during postoperative adjuvant radiotherapy. The patients filled in the form independently without assistance from the staff, and returned them by mail or to the nurses. Informed consent was obtained to allow collection of additional data on cancer diagnosis and treatment. The study was approved by the Ethical Committee of Turku University Hospital and the University of Turku. Another part of the study focusing on depressive symptoms and unmet need for psychosocial support has been published elsewhere [3] .
Subjects
Three hundred and eighty-nine consecutive patients were contacted and 297 (76.3 %) returned the questionnaires. The patients had been operated for breast cancer and thereafter most patients (71 %) had been treated with six cycles of adjuvant chemotherapy. After this they come to receive postoperative radiotherapy, and the survey was conducted during the period of radiotherapy. Reasons for refusal were not explored. Patients with recurrent cancer (n = 10) were excluded. Fourteen patients were excluded due to incomplete answers on the questionnaires. Thus, 273 cases were available for analysis. Patients \53 years and patients C53 years (an arbitrary division of premenopausal and postmenopausal patients) were separately compared with the age-standardized female general population. Twenty-two patients did not consent to access to clinical records, and in another 22 cases, some requisite data were missing in the clinical records. Hence, the data of 229 patients could eventually be analyzed in a multivariate model when assessing the effect of clinical and treatment factors on HRQoL.
The data for the general population came from the National Health 2000 Health Examination Survey representing the Finnish population aged 30 and over supplemented with a sample of the population aged 18-29 years. For this analysis those individuals were selected, who were within the age range of the patients (n = 1,828, aged 24-52 years and n = 1,507 aged 53-83 years). These samples of the general population were weighted to correspond to the age distribution of the patients in the two groups.
Instruments
HRQoL
Health-related quality of life was measured using the 15D instrument [10] , which is a 15-dimensional, standardized self-administered measure of HRQoL. It has also been used in assessing HRQoL in cancer patients [11, 12] . The 15D is applicable both as a single index and profile instrument. The dimensions are mobility, vision, hearing, breathing, sleeping, eating, speech, excretion, usual activities, mental function, discomfort and symptoms, depression, distress, vitality and sexual activity. Each dimension is divided into five levels. The patient chooses the level best describing her current situation for each dimension.
The single index (15D score) on a 0-1 scale, representing the overall HRQoL (0 = deceased, 1 = full health), is calculated from the health state descriptive system by summing up over all dimensions a set of population-based preference or utility weights. The weight for each level of each dimension is obtained by multiplying the level value by the importance weight of the dimension at that level. The level values on a 0-1 scale, reflecting the goodness of the levels relative to no problems on the dimension and to being dead, and the importance weights summing up to unity, have been previously elicited from representative population samples. A change of C|0.03| in the 15D score is clinically important in the sense that subjects can on average feel the difference. This means that when a mixed group of patients were asked 6 months after treatment, if they felt their health status had changed during the treatment, those who felt a health status change had a 15D score change on average about ?0.03 or -0.03 [13] . A difference C0.03 is used to determine clinical significance in the presence of statistical significance. The mean dimension values are used in creating the 15D profile for a given group of patients. A maximum of three missing values on the dimensions can be quite accurately replaced by a regression technique using the other dimensions and other known characteristics of the individual (e.g. age) as explanatory variables [13] . In the important properties (reliability, validity, sensitivity) the 15D compares at least equally with other preference-based generic HRQoL instruments [14] .
Depressive symptoms
Depressive symptoms were measured by the 21-item Beck Depression Inventory (BDI) [15] . A BDI score C10 indicates depressive symptoms. In our study, the third option in item 9 (I shall kill myself when I get the chance) was omitted as patients filled in the questionnaires by themselves at home perhaps without the possibility of discussing emergent thoughts with anyone. If a patient had\5 missing items, they were replaced by the mean of the other items filled in. In cases with more missing items, the patient was left out of the analyses.
Statistics
Continuous variables were characterized by means and standard deviation and categorical variables by frequencies and percentages. The Mann-Whitney U test was used to test the differences in the continuous variables (15D total score and 15D dimension level values) between the age groups and between patients and age-standardized controls. Using analysis of covariance (ANCOVA), HRQoL was analyzed for the effect of clinical and treatment factors (BDI, age group, metastatic axillary lymph nodes, hormone receptor status, chemotherapy and type of surgery). In further analyses, also interactions between factors and age groups were tested. Residuals were checked for justification of the analysis. p values of \0.05 were considered statistically significant. SAS System for Windows, version 9.2 (SAS Institute Inc., Cary, NC) was used for statistical analyses.
Results
Characteristics of breast cancer patients
The characteristics of the study patients are set out in Table 1 . The mean age of participants was 57.7 years (SD 9.8). Time from first cancer diagnosis was on average 7.0 months (2.5). The mean BDI score was 8.4 (7.3), and 32.1 % had a BDI score C10 indicating depressive symptoms.
HRQoL in breast cancer patients \53 years versus breast cancer patients C53 years There was no difference in 15D score between the age groups (p = 0.15). On single dimensions, however, there were differences: the older group did better on usual activities (p = 0.013), depression (p = 0.005), and sexual activity (p = 0.004) while the younger group had higher values on the dimension of mobility (p = 0.023). (Data not shown).
HRQoL in breast cancer patients versus the agestandardized general population
In patients \53 years, 15D score was lower than in agematched controls in a statistically significant (p \ 0.001) (Fig. 1) . There was no difference in 15D score between patients C53 years and controls. Among single dimensions, however, the level of HRQoL in patients was lower on the dimensions of sleeping (p = 0.004), depression (p = 0.010), distress (p \ 0.001) vitality (p = 0.027), and sexual activity (p \ 0.001). In contrast, the patients did better than controls on discomfort and symptoms (p \ 0.001) (Fig. 2) .
Determinants of HRQoL in breast cancer patients
The factors associated with 15D score in the multivariate model are shown in Table 2 . Depressive symptoms were associated negatively with HRQoL (p \ 0.001). Having had mastectomy instead of breast-conserving surgery was significantly (p = 0.018) and having no axillary metastases was nearly significantly (0.058) associated with better HRQoL.
In further analyses, an interaction between depressive symptoms and age was found (age group 9 depressive symptoms interaction, p \ 0.001). The negative effect of depressive symptoms on HRQoL was stronger in patients C53 years (regression coefficient b -0.011, 95 % CI -0.012 to -0.010, p \ 0.001) than in the younger age group (b -0.007, 95 % CI -0.009 to -0.005, p \ 0.001). The effect of surgery was different between the age groups (interaction between age group 9 type of surgery, p = 0.041). Having mastectomy instead of breast-conserving surgery was associated positively with HRQoL in the younger (b 0.045, 95 % CI 0.009-0.081, p = 0.016) but not in the older age group (b 0.008, 95 % CI 0.012-0.027, p = 0.431).
Discussion
Both pre-and postmenopausal-aged breast cancer patients differed from the general female population in Finland (GFP) in several aspects of HRQoL, particularly in psychological aspects and depressive symptoms. Overall the HRQoL among younger patients was lower than that of the GFP. Impairment in HRQoL was more marked among patients with depressive symptoms and among younger patients after breast-conservative surgery. Although breast conservation is important for the body image, it may remind the patients of the presence of cancer more than a mastectomized breast. Younger patients evinced more depressive symptoms compared to older patients (which Fig. 2 The 15D profile for breast cancer patients C53 years (n = 197) and age-standardized sample of female general population (n = 1,507). The profile has been created by using the mean dimension levels of the 15D. Popul = general population. Move = mobility. See = vision. Hear = hearing. Breath = breathing. Sleep = sleeping. Eat = eating. Speech = speech. Excret = excretion. Uact = usual activities. Mental = mental function. Disco = discomfort and symptoms. Depr = depression. Distr = distress. Vital = vitality. Sex = sexual activity was shown in the first part of our study [3] ), but the impact of depressive symptoms on HRQoL was more significant in the latter group.
The results of the current study on HRQoL are mostly in line with previous reports: Arndt and associates [4] studied breast cancer patients in Germany 1 year after diagnosis and observed no difference in total score results compared with general population. Nevertheless, deficits among women with breast cancer were observed for emotional, social, role and cognitive functioning. These deficits were predominantly found in younger age groups. More recently Schleife et al. [9] from Germany reported that in almost all aspects of QoL patients deviated from the general population, but not in depression or anxiety, and regardless of age. Also a group with Paskett et al. [6] , using the RAND 36-item Health Survey HRQoL, reported significantly poorer physical functioning and general health regardless of the age of breast cancer patients compared to the general female population. Lee and associates [7] (Korea) similarly reported lower HRoQL at baseline and at 1 year after diagnosis among breast cancer patients compared to the general population. Particular problems among patients comprised fatigue, perception of pain and insomnia. In Sweden [8] , breast cancer patients were observed to have poorer HRQoL than what was measured in the general population, this in line with the findings in the current study. A similar trend was seen in Norway [5] both at baseline and at 3 and 12 months in social and cognitive functioning, although the total score did not differ: in the report in question the results favored the elderly patient population. Younger patients in the current study had lower total scores compared to the general female population whereas among older breast cancer patients no difference was observed.
Impaired vitality was reported by all breast cancer patients compared to GFP. Vitality is comparable to fatigue, which has been widely studied in the context of breast cancer [16, 17] . Associations of fatigue with depression and sleep disorders among cancer patients have previously been reported [18, 19] . Radiotherapy has been associated with increased perception of fatigue in several studies [18, 20] , also among older breast cancer patients with good prognosis and without a compromising total score on QoL [21] . Having depressive symptoms/depression prior to radiotherapy or at baseline has proved predictive to fatigue during radiotherapy [21] . Even if no difference was observed in HRQoL at baseline and after radiotherapy in another study [2] , fatigue and breast symptoms were reportedly increased during radiotherapy. Awareness of these findings can help staff and patients to adapt to symptoms developing during postoperative breast cancer radiotherapy and motivate for intervention and rehabilitation.
In the current study among Finnish breast cancer patients the factors impairing HRQoL were depressive symptoms and breast-conserving surgery, while spread of cancer in axillary lymphnodes did not quite reach significance. The effects of depression and spread of cancer on HRQoL have been found in previous reports [22] [23] [24] . More controversy is seen in reports comparing mastectomy and breast conserving surgery: Pockaj et al. [25] reviewed the published data and found no significant difference between the two modes of operation in HRQoL. Even if the decision on the extent of surgery was made with full patient consent, more depressive symptoms 1 year after breast conserving treatment were reported compared to patients having undergone mastectomy [26] . In our study, in the younger age group but not in the older group, patients with breastconserving surgery had a poorer HRQoL than patients with mastectomy. The idea of cancer relapse, which patients may link to breast-conserving surgery, may constitute a greater fear for younger women with active family and occupational roles in comparison with older women. The first part of our study [3] showed that younger patients were more depressive than the older ones. The effect of depressive symptoms on HRQoL was significant in both age groups, but it was stronger among the older patients, which may relate to other socio-economic factors which were not assessed in this study and warrant further investigation.
In overcoming the HRQoL impairment and adapting back to normal activities it seems that breast cancer patients could benefit from rehabilitation. Economic evaluations of rehabilitation programs have shown favourable cost-effectiveness ratios [27] . Thus, rehabilitation intervention could be considered for the most vulnerable patients, who can be identified through screening during adjuvant therapy. Mewes and associates [27] systematically reviewed the data published on sixteen effectiveness and six cost-effectiveness studies. Multidimensional rehabilitation programs were found to be effective, but not more so than monodimensional interventions, and not on all outcome measures.
The limitations in the current study are due to lack of socio-demographic factors in the analysis. Further, we did not have access to the previous psychiatric history of the patients. If available, these could help to characterize more specifically the most vulnerable group among breast cancer patients. Considering the methods, using depressive symptoms as an independent variable and 15D score as a dependent variable in the same model may be problematic, because depression is one of the 15 dimensions in the 15D.
Currently most breast cancer patients in Finland receive radiotherapy after a period of adjuvant chemotherapy. It could be assumed that moving on to postoperative radiotherapy would already mean recovery and help patients back to normalized life. However, during this period especially younger breast cancer patients seem to suffer from depressive symptoms and their HRQoL is impaired compared to the general female population. The strongest influence on HRQoL was attributable to depressive symptoms. Therefore screening for symptoms, supportive actions and rehabilitation should also be available.
